1. Home
  2. GNFT vs SENS Comparison

GNFT vs SENS Comparison

Compare GNFT & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • SENS
  • Stock Information
  • Founded
  • GNFT 1999
  • SENS 1996
  • Country
  • GNFT France
  • SENS United States
  • Employees
  • GNFT N/A
  • SENS N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • SENS Industrial Machinery/Components
  • Sector
  • GNFT Health Care
  • SENS Industrials
  • Exchange
  • GNFT Nasdaq
  • SENS Nasdaq
  • Market Cap
  • GNFT 179.7M
  • SENS 619.1M
  • IPO Year
  • GNFT 2019
  • SENS N/A
  • Fundamental
  • Price
  • GNFT $3.91
  • SENS $0.92
  • Analyst Decision
  • GNFT Strong Buy
  • SENS Strong Buy
  • Analyst Count
  • GNFT 1
  • SENS 1
  • Target Price
  • GNFT $13.00
  • SENS $2.00
  • AVG Volume (30 Days)
  • GNFT 9.9K
  • SENS 20.3M
  • Earning Date
  • GNFT 09-19-2024
  • SENS 02-27-2025
  • Dividend Yield
  • GNFT N/A
  • SENS N/A
  • EPS Growth
  • GNFT N/A
  • SENS N/A
  • EPS
  • GNFT 0.47
  • SENS N/A
  • Revenue
  • GNFT $86,225,222.00
  • SENS $22,205,000.00
  • Revenue This Year
  • GNFT $145.20
  • SENS $0.43
  • Revenue Next Year
  • GNFT N/A
  • SENS $60.55
  • P/E Ratio
  • GNFT $7.89
  • SENS N/A
  • Revenue Growth
  • GNFT 175.45
  • SENS 11.41
  • 52 Week Low
  • GNFT $3.35
  • SENS $0.25
  • 52 Week High
  • GNFT $6.42
  • SENS $1.20
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 54.95
  • SENS 56.43
  • Support Level
  • GNFT $3.68
  • SENS $0.79
  • Resistance Level
  • GNFT $3.96
  • SENS $0.95
  • Average True Range (ATR)
  • GNFT 0.13
  • SENS 0.12
  • MACD
  • GNFT 0.05
  • SENS -0.02
  • Stochastic Oscillator
  • GNFT 79.49
  • SENS 42.02

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: